Transplanting GABAergic cells derived from human-induced pluripotent stem cells into mice resulted in safe, lasting, and effective relief from extreme neuropathic pain. Researchers hope to begin human testing within five years.
Open sharing of scientific data and standard methods will allow researchers to collaborate on projects and accelerate understanding of neurodegenerative diseases.
Two new studies are helping to enhance how schizophrenia affects the workings of the brain and opens new approaches for future treatment options.
Mutations in the alpha-synuclein gene can cause increased vulnerability to pesticides, which may lead to Parkinson's disease.